New Drug May Help Fight Certain Advanced Lung Cancers
In trial, ganetespib extended survival for people with a very common form of the diseaseContinue Reading
In trial, ganetespib extended survival for people with a very common form of the diseaseContinue Reading
Lambrolizumab activates body’s immune system to kill cancerous cells, researchers sayContinue Reading
Sorafenib appeared to delay disease progression, shrink tumors in early studyContinue Reading
Women who got the drug plus standard chemo lived about 4 months longer on averageContinue Reading
Study found it prolonged remission after chemotherapy almost six months longer than a placeboContinue Reading
In preliminary trial, nivolumab shrank tumors in 30 percent of tough-to-treat patientsContinue Reading
10 years on the drug did increase side effects, but survival gains may be worth it, researchers sayContinue Reading
Tumor growth suppressed in lab tests; human trials still needed, study authors sayContinue Reading
253-day journey would expose astronaut to amount equal to 40-50 whole-body scans, study saysContinue Reading
A little ‘short-term hassle’ may have prevented stage 2 cancer, Wisconsin resident saysContinue Reading
Though new techniques are on the horizon, doctors say colon-cleansing is here to stayContinue Reading
Gap in longevity between better- and least-educated women is growing, study findsContinue Reading
Despite health risks associated with tanning, many young women still prefer the real thingContinue Reading
Majority would give a prescription to an advanced cancer patient in painContinue Reading
© 2021 TheHealthCast.com - All Rights Reserved.